Introduction
Introduction

Minerval (2-hydroxyoleic acid) is a synthetic oleic acid (OA) derivative that binds to the plasma membrane and alters lipid organization
, triggering a series of events that impairs lung cancer (A549) cell proliferation [2, 3] . OA and structural analogues (e.g. Minerval) modulate the plasma membrane lipid structure by increasing its propensity to form nonlamellar (hexagonal HII) phases [4, 5] . This modulation of the membrane lipid structure influences the localization and activity of amphitropic membrane proteins involved in cell signalling, such as G proteins and protein kinase C [6] [7] [8] [9] [10] ' , are specific to the apoptotic pathway used. Thus, caspase-8 is associated with the 'extrinsic' membrane death receptor pathway and caspase-9 with the 'intrinsic' mitochondrial pathway [11] . Through proteolysis, these proteins activate 'effector caspases ' (e.g. caspase-3, -6 and -7) , which are also known as 'executioner' caspases because their activity results in the widespread cleavage of a variety of target proteins [12] . Here we showed that Minerval markedly induced apoptosis, preferentially through the 'extrinsic' 
. This antiproliferative effect of Minerval is not accompanied by apoptosis in A549 lung cancer cells. The present study was designed to investigate the pharmacological effectiveness of this drug in a number of cancer cell lines and the mechanism of action triggered by Minerval in these cells. In this context, it was found that this drug induced apoptosis in most cell lines studied, whereas it did not significantly affect normal fibroblasts. Moreover, it also impaired tumour progression and induction of cancer cell death in an animal model of leukaemia without apparent toxicity. Programmed cell death or apoptosis can be triggered by external signals propagated within the cell either by receptors in the plasma membrane (extrinsic pathway), or by signals generated in the mitochondria (intrinsic pathway). In both pathways, the events that provoke apoptosis involve the activation of previously dormant cysteine-proteases called caspases. The first caspases activated by such cell death signals, the 'initiator caspases
Minerval induces apoptosis in Jurkat and other cancer cells
Results
Effects of Minerval on Jurkat cell proliferation
We studied the effects of Minerval on Jurkat (human T-lymphoblast leukaemia) cells because treatments with this molecule increase the survival rate of mice infected with murine leukaemia cells (84% and 0% survival for mice treated and untreated with Minerval, respectively) [2] and the molecular mechanisms involved in this anti
1D). This impairment of Jurkat (leukaemia) cell growth by Minerval was in agreement with previous results showing induction of the cell cycle arrest in A549 (lung cancer) cells. Inhibition of Jurkat cell proliferation was associated with marked decreases in cyclin D3 and cdk2 with respect to ␣-tubulin (Fig. 1E). Hence, the molecular mechanism of the anti-tumourigenic effects of Minerval in Jurkat cells appeared to be in part similar to that (antiproliferative) described in A549 cells [2]. In addition, it was also demonstrated that the modest chemical difference between
Minerval and OA (one oxygen atom) had a marked effect on the pharmacological activity of these fatty acids. (Fig. 2D) (Fig. 3) . (Fig. 4) (Fig. 4) (Fig. 5 ).
Minerval induces apoptosis in Jurkat cells
In previous studies, it was shown that apoptosis was not involved in the anti-cancer effects of Minerval on human lung adenocarcinoma (A549) cells [2]. In contrast, Minerval did induce apoptosis in human leukaemia cells. As determined by flow cytometry of ethidium bromide stained cells, Minerval treatments induced DNA breakage (increases in sub-G1 peaks, Fig. 2A). When the sub-G1 peak was quantified it became clear that the apoptotic effect of Minerval was both time-and concentration-dependent. After a 72-hr exposure to 100 M Minerval a 20-fold increase in the proportion of apoptotic cells was observed (from 3.4 Ϯ 0.4% to 69.5 Ϯ 4.9% in the absence and presence of Minerval, respectively). This time-and concentration-dependent effect of Minerval was most probably responsible for the reversion of leukaemia in animal models [2], because greater concentrations of this drug induced total depletion of cancer cells in cultures (data not shown). Minerval also induced a marked and concentration-dependent increase in the proteolytic cleavage of PARP, a molecular marker of apoptosis (Fig. 2B). On the other hand, the presence of Minerval (50 M, 6 hrs) induced changes in membrane structure that induced membrane raft disorganization and capping of Fas receptor in Jurkat cell membranes
001). (D) Labelling of Fas receptor and GM1 (membrane rafts, mb. raft) in Jurkat cells cultured for 48 hrs in the presence (M50, 50 M) or absence (Control) of Minerval. Capping of Fas receptors (arrows) and membrane raft disorganization upon treatment with Minerval were observed using confocal microscopy (bar ϭ 4 m). For further details see text.
Caspase-8 mediates the effects of Minerval on Jurkat cells
Effector caspases can be activated by two general pathways: the 'extrinsic' membrane death receptor pathway that is associated with caspase-8 activation; and the 'intrinsic' mitocondrial pathway that is associated with caspase-9 activation. As an approximation to determine which of these pathways might be involved in Minerval-induced apoptosis, we determined the effects of inhibition of caspase-8 (using the inhibitor zIETD-fmk) and caspase-9 (using the inhibitor zLEHD-fmk) on the apoptosis of Jurkat cells induced by 50 M Minerval during 72 hrs. The inhibition of caspase-8 activity (the extrinsic pathway) significantly reduced the occurrence of apoptotic events in Jurkat cells treated with Minerval
Molecular mechanisms of the anti-cancer action of Minerval in different cancer cell lines
We also studied the molecular mechanisms involved in the pharmacological action of Minerval in several cancer cell lines and non-tumour fibroblasts (Table 1) [1, 4] . Nonlamellar-phase propensity has been shown to regulate the interaction of signalling proteins with membranes, such as G proteins and PKC [2, [7] [8] [9] , which are fundamental in the control of cell proliferation and other important cell functions [20, 21] . As such, the effects of Minerval and structurally related fatty acids (e.g. OA) have been associated with their influence on the activity of these signalling proteins induced by the alterations in membrane lipid structure [4, 5, 15] [7, 9, 15] . Moreover, regulation of membrane lipid structure has proven to be a good strategy to treat a number of human pathologies [14] . In this context, the plasma membrane is involved in the mode of action of several anti-tumour drugs, such as anthracyclines, hexamethylene bisacetamide, and Minerval [1, 2, 8, 15, 22, 23] [29] , a decrease in cyclin D3 is associated with the induction of apoptosis in T-lymphocytes [30] . Similarly, cdk2 repression and down-regulation has anti-proliferative effects in A549 cells [2] and pro-apototic effects in Jurkat cells [31] . Therefore [11, 33] [2] . In line with this, epidemiological and experimental studies have shown that the intake of free fatty acids reduces the incidence of several types of cancer [35] [36] [37] [38] [39] [40] [41] . Moreover, fatty acids with a lesser rate of metabolic degradation show a greater potency against tumour growth [35] [36] [37] [38] [39] [40] [41] . Therefore, the reduced clearance of Minerval from the cell would directly enhance the effects of OA on membrane structures and cell signalling.
. For this purpose, cell viability was determined, cell DNA content was quantified and determined the proportion of cells in the various phases of the cell cycle (G0/G1, S and G2/M) or in apoptosis (sub-G1 peaks) in the absence or presence of Minerval (25-400 M) at different incubation times
Fig. 3 Upper panels: phase contrast microscopy (original magnification ϫ 400) of Jurkat cells cultured for 72 hrs in the presence (M) or absence (C) of 50 M Minerval. Minerval-treated cells show membrane blebbing and budding and cellular degeneration which was further assessed by electron microscopy. Lower panels: transmission electron microscopy of Jurkat cells incubated in the absence (Control, C, left, original magnification ϫ 5,000) or presence of Minerval (M, right, original magnification ϫ 8,000). The right TEM panels show in detail two apoptotic bodies also observed by phase contrast microscopy in the presence of Minerval. N, nucleus; Mi, mitochondria; L, lipid vesicles.
Fig. 4 Effect of caspase-8 and caspase-9 inhibition on Minerval-induced apoptosis. (A) DNA content in Minerval-treated cells (50 M) in the presence of caspase-8 (left) or caspase-9 (right) inhibitors. Basal apoptosis in the presence of 50 M Minerval was 21.1% of the cells in culture. (B) Jurkat cells were cultured for 72 hrs in the presence or absence (open bars) of 25 (M25, grey bars) or 50 M (M50, black bars) of Minerval, and in the presence or absence (control) of caspase-8 and caspase-9 inhibitors. C, PARP fragmentation in untreated Jurkat cells (control, C) and in cells treated with 50 M Minerval in the presence or absence (M) of the caspase-8 inhibitor (MϩC8I) or the caspase-9 inhibitor (Mϩ9I). Immunoreactive ␣-tubulin bands from cells treated as above are also shown.
Fig. 5 Effect of Minerval treatments on tumour growth in mice. (A) Nude mice were infected with Jurkat cells by s.c. injection on the dorsal surface. Ten days after implantation, tumours were measured and then animals were treated with vehicle (Control, grey bars) or Minerval (black bars) for another 21 consecutive days. The bars correspond to the mean Ϯ SEM values of tumour volume at day 10 (before treatment) and 31 (end of treatment) postimplantation. (B) Histopathological analysis of tumours dissected from vehicle-(Control, left) and Minerval-treated (right) animals. Tumours from control animals showed a homogeneous histological organization, being most cells alive. In tumours from animals treated with Minerval (which were smaller than those from vehicle-treated animals), the greatest region corresponded to that of dead cells (1), followed by a transition area (2) containing dead cells and cells with pycnotic nuclei and a small region (3) in which most cells were alive. The lower micrographs of this panel show that most cells in Minerval-treated animals underwent apoptosis (TUNEL). (C) Immunoblotting detection of caspase-8, caspase-9 and tubulin in tumours from untreated (Control) and Minerval-treated (M) mice. (0-144 hrs). Apoptosis was further assessed by quantification of PARP degradation in the absence or presence of Minerval. The mechanism of action of Minerval was assigned to induction of the cell cycle arrest (anti-proliferative, P) when the number of cells was reduced, they accumulated in the G0/G1 phase and no PARP degradation was observed, whereas degradation of this enzyme along with the presence of a sub-G1 peak (produced by DNA degradation) was associated with induction of apoptosis (A)
.
Discussion
The present study shows that Minerval turned on the apoptotic machinery in most cancer cell lines studied (9 out of 12 cell lines). In turn, inhibition of cell proliferation (i.e. exit from the cell cycle) was the sole mechanism triggered by this drug in three cell lines (Table 1). In contrast, Minerval did not induce anti-proliferative, pro-apoptotic, or any kind of cytotoxic effects in non-tumour cells (IMR90 fibroblasts). These results explain in part the activity of this drug against various types of cancer. In addition, these data further indicate a lack of cytotoxic effects in normal tissues, which in fact has been reported in previous histopathological studies in various tissues from rats treated with high doses of Minerval [2] and in formal and independent preclinical studies (data not shown). Evasion of apoptosis is one of the hallmarks of cancer cells and one of the aims of novel therapies designed against can
Protein-lipid interactions play a crucial role in signal propagation [42, 43] and Minerval can regulate membrane physical properties involved in such interactions [1, 2] . This constitutes a new therapeutic approach (membrane-lipid therapy), based on regulation of membrane lipid structure and subsequent modification of cell signalling [14] . In this study, we showed that apoptosis appeared to be the preferential mechanism of action induced by Minerval 
